Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Cash & Equivalents (2016 - 2026)

Alkermes has reported Cash & Equivalents over the past 16 years, most recently at $388.6 million for Q4 2025.

  • Quarterly Cash & Equivalents rose 33.46% to $388.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $388.6 million through Dec 2025, up 33.46% year-over-year, with the annual reading at $388.6 million for FY2025, 33.46% up from the prior year.
  • Cash & Equivalents was $388.6 million for Q4 2025 at Alkermes, down from $616.4 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $665.8 million in Q2 2023 and troughed at $205.0 million in Q1 2021.
  • The 5-year median for Cash & Equivalents is $363.1 million (2021), against an average of $393.3 million.
  • Year-over-year, Cash & Equivalents surged 161.46% in 2023 and then crashed 38.82% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $337.5 million in 2021, then dropped by 13.35% to $292.5 million in 2022, then skyrocketed by 56.41% to $457.5 million in 2023, then crashed by 36.36% to $291.1 million in 2024, then soared by 33.46% to $388.6 million in 2025.
  • Per Business Quant, the three most recent readings for ALKS's Cash & Equivalents are $388.6 million (Q4 2025), $616.4 million (Q3 2025), and $521.2 million (Q2 2025).